Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Weekly exposure (57 days/week) Weekly Exposure From the 1:1 Pre-blended Vial Daily blend dose 0.5 mg/day Weekly total blend 2.53.5 mg Weekly BPC-157 1.251.75 mg Weekly TB-500 1.251.75 mg Daily blend dose 1.0 mg/day Weekly total blend 5.07.0 mg Weekly BPC-157 2.53.5 mg Weekly TB-500 2.53.5 mg Daily blend dose 1.5 mg/day Weekly total blend 7.510.5 mg Weekly BPC-157 3.755.25 mg Weekly TB-500 3.755.25 mg Daily blend dose 2.0 mg/day Weekly total blend 10.014.0 mg Weekly BPC-157 5.07.0 mg Weekly TB-500 5.07.0 mg Use this to compare a blend schedule against the separate-vial weekly totals in the next tab
Through their involvement in lipid (fat) metabolism, lipotropics help to maintain a healthy liver
Pioglitazone and bladder cancer risk: a systematic review and meta-analysis
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, et al
Peptides work by intervening at specific points in this process, amplifying what works and suppressing what causes further damage
AOD-9604 stimulates lipolysis and inhibits fat cell formation, CB4211 enhances insulin sensitivity and fatty acid metabolism, and Tesamorelin targets visceral fat through growth hormone-mediated pathways
